Abstract:1-Deoxysphingolipids (deoxySLs) are atypical sphingolipids of clinical relevance as they are elevated in plasma of patients suffering from hereditary sensory and autonomic neuropathy (HSAN1) or type 2 diabetes. Their neurotoxicity is described best but they inflict damage to various cell types by an uncertain pathomechanism. Using mouse embryonic fibroblasts and an alkyne analog of 1-deoxysphinganine (doxSA), the metabolic precursor of all deoxySLs, we here study the impact of deoxySLs on macroautophagy/autophagy, the regulated degradation of dysfunctional or expendable cellular components. We find that deoxySLs induce autophagosome and lysosome accumulation indicative of an increase in autophagic flux. The autophagosomal machinery targets damaged mitochondria that have accumulated N-acylated doxSA metabolites, presumably deoxyceramide and deoxydihydroceramide, and show aberrant swelling and tubule formation. Autophagosomes and lysosomes also interact with cellular lipid aggregates and crystals that occur upon cellular uptake and N-acylation of monomeric doxSA. As crystals entering the lysophagosomal apparatus in phagocytes are known to trigger the NLRP3 inflammasome, we also treated macrophages with doxSA. We demonstrate the activation of the NLRP3 inflammasome by doxSLs, prompting the release of IL1B from primary macrophages. Taken together, our data establish an impact of doxSLs on autophagy and link doxSL pathophysiology to inflammation and the innate immune system.Abbreviations: alkyne-doxSA: (2S,3R)-2-aminooctadec-17yn-3-ol; alkyne-SA: (2S,3R)-2- aminooctadec-17yn-1,3-diol; aSA: alkyne-sphinganine; ASTM-BODIPY: azido-sulfo-tetramethyl-BODIPY; CerS: ceramide synthase; CMR: clonal macrophage reporter; deoxySLs: 1-deoxysphingolipids; dox(DH)Cer: 1-deoxydihydroceramide; doxCer: 1-deoxyceramide; doxSA: 1-deoxysphinganine; FB1: fumonisin B1; HSAN1: hereditary sensory and autonomic neuropathy type 1; LC3: MAP1LC3A and MAP1LC3B; LPS: lipopolysaccharide; MEF: mouse embryonal fibroblasts; MS: mass spectrometry; N3635P: azido-STAR635P; N3Cy3: azido-cyanine 3; N3picCy3: azido-picolylcyanine 3; NLRP3: NOD-like receptor pyrin domain containing protein 3; P4HB: prolyl 4-hydroxylase subunit beta; PINK1: PTEN induced putative kinase 1; PYCARD/ASC: PYD and CARD domain containing; SPTLC1: serine palmitoyltransferase long chain base subunit 1; SQSTM1: sequestosome 1; TLC: thin layer chromatography.

1-Deoxysphingolipids and Their Analogs in Foods: the Occurrence and Potential Impact on Human Health

Sphingolipids in Food and Their Critical Roles in Human Health

1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma

Sphingolipids in foodstuff: Compositions, distribution, digestion, metabolism and health effects – A comprehensive review

A review of sphingolipids from marine sources and their analytical method, metabolic process, and essential roles in human health

Analysis of 1-Deoxysphingoid Bases and Their N-Acyl Metabolites and Exploration of Their Occurrence in Some Food Materials

Ongoing Studies of Novel 1‐deoxy‐sphinglipids in Food

Polysaccharides derived from natural sources regulate lipid metabolism: A review of the mechanisms

1-Deoxysphingolipids cause autophagosome and lysosome accumulation and trigger NLRP3 inflammasome activation

Qualitative Distribution of Endogenous Sphingolipids in Plasma of Human and Rodent Species by UPLC-Q-Exactive-MS.

Deoxysphingolipids activate cGAS-STING in colon cancer cells and enhance tumor immunity

Perspective: Therapeutic Implications for Sphingolipids in Health and Disease

The nutritional functions of dietary sphingomyelin and its applications in food

Analytical advances in the determinations of dietary sphingolipids in milk, dairy products, and infant formula and impacts on human health

The Effect of Dietary Sphingolipids on Plasma Sphingomyelin Metabolism and Atherosclerosis.

Regulation of cellular and systemic sphingolipid homeostasis

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

Sphingolipids In Obesity And Related Complications

Sphingomyelin Biosynthesis: Its Impact on Lipid Metabolism and Atherosclerosis

Implications of Sphingolipids on Aging and Age-Related Diseases

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology